New Developments in Medical Management of Endometriosis

Harmeet Malhotra
In: Apollo Medicine · 2009 · vol. 6(3) , pp. 247–250 · doi:10.1016/s0976-0016(11)60534-6 · W1994405792
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-16 ⓘ

This paper reviews current hypoestrogenic endometriosis treatments and novel immunomodulatory therapies arising from the comparison of endometriosis to autoimmune disorders, aiming for fertility-sparing options.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a chronic recurring disease in women of reproductive age. Current treatment modalities used to manage the disease primarily aim to induce a hypoestrogenic state which leads to a reduction in symptoms and endometriotic implants. With new developments in the understanding of pathophysiology of endometriosis, it is being compared to autoimmune disorder. Newer therapies using immunomodulators and other novel compounds are discussed. An ideal drug would be one that treats endometriosis without hampering fertility.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (17)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK